Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Apheresis|May 14, 2005
Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstimMassimo Martino, Giuseppe Console, Giuseppe Irrera, et al.
Frontiers in Oncology|July 7, 2020
Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case ReportCirino Botta, Nadia Caruso, Sabrina Bossio, et al.
Expert Opinion on Pharmacotherapy|September 24, 2013
An old drug with a new future: bendamustine in multiple myelomaMassimo Gentile, Anna Grazia Recchia, Carla Mazzone, et al.
Transfusion|March 5, 2014
Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter studyGiambattista Bertani, Luca Santoleri, Massimo Martino, et al.
Cancers|January 10, 2026
Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?Caterina Alati, Martina Pitea, Matteo Molica, et al.
Leukemia Research|October 27, 2005
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantationSara Galimberti, Edoardo Benedetti, Fortunato Morabito, et al.
Expert Opinion on Investigational Drugs|October 4, 2017
Venetoclax for the treatment of chronic lymphocytic leukemiaMassimo Gentile, Annamaria Petrungaro, Giuseppina Uccello, et al.
Expert Opinion on Biological Therapy|July 14, 2012
Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient programMassimo Martino, Mauro Montanari, Benedetto Bruno, et al.
Cytotherapy|September 10, 2025
Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: A Delphi consensusStefano Luminari, Annalisa Chiappella, Alice Di Rocco, et al.
Tumori|June 15, 2007
Utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors treated with G-CSF for mobilization of peripheral blood stem cellsMassimo Martino, Francesca Luise, Vincenzo Oriana, et al.
Pageof 17